Li Dean Y 4
4 · Merck & Co., Inc. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Merck (MRK) EVP/President Li Dean Y Sells 10,235 Shares
What Happened
Li Dean Y, Executive Vice President & President of Merck Research Laboratories (MRL), sold 10,235 Merck shares in an open-market sale on February 10, 2026. The reported weighted-average price was $117.52 per share (range shown below), generating roughly $1,202,844 in proceeds. This was a sale (liquidity event), which is typically routine and does not by itself indicate a change in company outlook.
Key Details
- Transaction date: 2026-02-10 — open market sale (transaction code S).
- Shares sold: 10,235 at a weighted-average price of $117.52; total proceeds ≈ $1,202,844.
- Price range disclosed: $117.5200 to $117.5550; the filing notes the price is a weighted average and the filer can provide per-price details on request.
- Shares owned after transaction: Not reported in this Form 4.
- Filing timeliness: Reported with a period of report matching the transaction date (no late filing indicated in this record).
Context
Sales by executives are often for personal liquidity or routine reasons; purchases generally carry more informational weight for investors. The filing includes a footnote clarifying the sale was executed in multiple trades at slightly different prices (hence the weighted average).
Insider Transaction Report
- Sale
Common Stock
[F1]2026-02-10$117.52/sh−10,235$1,202,844→ 92,035.05 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.5200 to $117.5550, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.